CAS: 1429321-13-0
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | (2E)-2-[1-[5-(4-Bromophenyl)-4-hydroxy-3-thienyl]ethylidene]hydrazide-5-[[[[4-[[(2-hydroxyethyl)amino]carbonyl]phenyl]methyl]amino]carbonyl]-2-thiophenecarboxylic Acid REF: TR-B701335CAS: 1429321-13-0 | - - - | 24.466,00 € | Lun 14 Abr 25 |
 | TA-316 REF: TM-T13769CAS: 1429321-13-0 | 98% | 651,00 €~3.800,00 € | Mar 03 Jun 25 |
![(2E)-2-[1-[5-(4-Bromophenyl)-4-hydroxy-3-thienyl]ethylidene]hydrazide-5-[[[[4-[[(2-hydroxyethyl)...](https://static.cymitquimica.com/products/TR/thumb/B701335.jpg)
(2E)-2-[1-[5-(4-Bromophenyl)-4-hydroxy-3-thienyl]ethylidene]hydrazide-5-[[[[4-[[(2-hydroxyethyl)amino]carbonyl]phenyl]methyl]amino]carbonyl]-2-thiophenecarboxylic Acid
Producto controladoCAS:1429321-13-0
Fórmula:
C28H25BrN4O5S2
Forma y color:
Neat
Peso molecular:
641.556
Ref: TR-B701335
| 100mg | 24.466,00 € |
Entrega estimada en Estados Unidos, el Lunes 14 de Abril de 2025
TA-316
CAS:1429321-13-0
Agent induces megakaryocytes/platelets from stem cells to treat thrombopenia.
Fórmula:
C28H25BrN4O5S2
Pureza:
98%
Forma y color:
Solid
Peso molecular:
641.56
Ref: TM-T13769
| 25mg | 2.157,00 € | ||
| 50mg | 2.832,00 € | ||
| 100mg | 3.800,00 € |
Entrega estimada en Estados Unidos, el Martes 3 de Junio de 2025
